Global Intrauterine Contraceptive Devices (IUD) Market By Type (Hormonal IUD and Copper IUD), By Distribution Channel (Hospital, Gynecology Clinics, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

Global Intrauterine Contraceptive Devices (IUD) Market size is expected to be worth around US$ 9.4 Billion by 2034 from US$ 6.5 Billion in 2024, growing at a CAGR of 3.8% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 39.6% share with a revenue of US$ 2.6 Billion.

Increasing demand for long-term, effective, and reversible contraceptive options is driving the growth of the intrauterine contraceptive devices (IUD) market. IUDs are widely used for birth control due to their high efficacy rates and convenience, offering a solution for women who seek a low-maintenance contraceptive method. The rising preference for non-hormonal birth control, as well as the growing awareness of family planning and reproductive health, has contributed to the increasing adoption of IUDs.

In July 2024, researchers at the University of Western Ontario introduced the development of an iron-based intrauterine device (IUD), offering a non-hormonal alternative to copper IUDs. By utilizing iron or zinc combined with a specially engineered polymer coating, this innovation seeks to reduce the side effects commonly associated with existing IUDs, potentially driving market growth by offering a more comfortable and effective contraceptive option.

Additionally, the rise of personalized healthcare and increasing access to reproductive health services are expanding opportunities for the market. Technological advancements in IUD materials, design, and insertion techniques are making the devices more comfortable and safer, further encouraging adoption.

The introduction of non-hormonal alternatives also taps into the growing segment of women seeking birth control without hormonal interference, providing significant market opportunities for product differentiation and innovation. As the global focus on reproductive rights continues to evolve, the IUD market is poised for sustained growth.

Key Takeaways

• In 2024, the market for Intrauterine Contraceptive Devices (IUD) generated a revenue of US$ 6.5 billion, with a CAGR of 3.8%, and is expected to reach US$ 9.4 billion by the year 2033.
• The type segment is divided into hormonal IUD and copper IUD, with hormonal IUD taking the lead in 2023 with a market share of 57.3%.
• Considering distribution channel, the market is divided into hospital, gynecology clinics, and others. Among these, hospital held a significant share of 52.8%.
• North America led the market by securing a market share of 39.6% in 2023.

Type Analysis

The hormonal IUD segment claimed a market share of 57.3% owing to its advantages in offering long-term contraception with additional health benefits. Hormonal IUDs are anticipated to become more popular because they not only provide effective birth control but also help in reducing menstrual bleeding and alleviating pain associated with menstruation.

As women seek more convenient and less invasive contraceptive methods, the hormonal IUD is likely to gain preference over other forms of birth control. The growing awareness about the health benefits of hormonal IUDs, combined with the increasing demand for long-acting reversible contraception, is projected to drive this segment’s growth. Additionally, the rising focus on personalized healthcare, where hormonal IUDs offer tailored solutions, is likely to contribute to the segment’s continued expansion in the global market.

Distribution Channel Analysis

The hospital held a significant share of 52.8% due to as hospitals continue to be a primary location for the provision of IUDs, especially in countries with advanced healthcare systems. The increasing demand for effective and long-term contraceptive options in hospitals, where comprehensive patient care and counseling services are available, is expected to drive the growth of this segment.

Hospitals offer a reliable platform for women to receive personalized medical advice and treatment related to family planning, leading to higher adoption rates of IUDs. Additionally, as hospitals continue to focus on expanding reproductive health services and improving maternal care, the demand for IUDs in this setting is projected to rise. The hospital segment is likely to remain a critical distribution channel for IUDs, offering both public and private healthcare options to women worldwide.

Key Market Segments

By Type

• Hormonal IUD
• Copper IUD

By Distribution Channel

• Hospital
• Gynecology Clinics
• Others

Drivers

The need for effective long-acting reversible contraception is driving the market

The need for effective long-acting reversible contraception is driving the intrauterine contraceptive devices (IUD) market. IUDs offer highly effective, long-term pregnancy prevention with minimal user intervention after insertion, appealing to individuals seeking reliable and convenient family planning options. Their extended duration of action and reversibility provide significant advantages over methods requiring frequent administration, contributing to their growing adoption.

Increased awareness among healthcare providers and patients regarding the benefits of long-acting reversible contraceptives fuels demand for IUDs. This sustained demand translates into market activity for companies providing these devices; for example, CooperCompanies, which includes IUDs in its portfolio through CooperSurgical, reported US$1.286 billion in revenue for its CooperSurgical segment in fiscal year 2024, reflecting the continued market for these and related women’s healthcare products.

Restraints

Perceived discomfort or pain during insertion and removal is restraining the market

Perceived discomfort or pain during insertion and removal is restraining the intrauterine contraceptive devices (IUD) market. The process of inserting and removing an IUD can cause discomfort or pain for some individuals, creating a significant barrier to their willingness to choose this method of contraception. Anxiety surrounding the procedure and insufficient access to adequate pain management options during insertion can deter potential users, despite the IUD’s high efficacy and long-term benefits.

Addressing these concerns through improved insertion techniques, better pain relief strategies, and comprehensive patient education is crucial for increasing market acceptance. The qualitative feedback and patient experiences frequently highlight pain as a deterrent factor influencing contraceptive method selection.

Opportunities

The increasing focus on expanding access to family planning services in low- and middle-income countries is creating growth opportunities

The increasing focus on expanding access to family planning services in low- and middle-income countries is creating significant growth opportunities for the intrauterine contraceptive devices (IUD) market. IUDs are a cost-effective and highly effective contraceptive method, making them particularly suitable for widespread implementation in family planning programs within resource-constrained settings.

International health organizations and national governments are actively working to improve the availability of and access to a variety of contraceptive options, including IUDs, to address unmet needs for family planning and reduce unintended pregnancies in these regions. Strengthening healthcare infrastructure, providing training for healthcare providers in IUD insertion and removal techniques, and ensuring consistent supply chains are essential steps in capitalizing on this market opportunity.

Organizations like the United Nations Population Fund (UNFPA) play a vital role in the procurement and distribution of contraceptive supplies, including IUDs, to countries with high unmet needs, demonstrating the ongoing commitment to expanding access as highlighted in their 2022-2023 report.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors influence the intrauterine contraceptive devices (IUD) market. Economic conditions impact healthcare spending by individuals, governments, and non-governmental organizations, affecting the affordability and accessibility of contraceptive services and supplies; during periods of economic prosperity, funding for family planning initiatives may increase, potentially boosting IUD availability, while economic downturns can lead to budget constraints that limit access.

Geopolitical stability is crucial for maintaining reliable global supply chains for the raw materials and components used in the manufacturing of these devices, as well as for the effective implementation of international family planning programs. Reports in early 2025 indicated that geopolitical risks were contributing to disruptions across various global supply chains, which can affect the medical device sector.

Despite potential negative impacts from economic fluctuations and geopolitical instability on funding and supply chains, the persistent worldwide need for effective contraception and the proven public health benefits of preventing unintended pregnancies through methods like IUDs ensure a strong underlying demand that supports continued production and distribution efforts globally.

Current US tariff policies can have an indirect impact on the intrauterine contraceptive devices (IUD) market by influencing the cost of imported raw materials or components used in the manufacturing process. The production of IUDs requires specialized materials, including medical-grade plastics and metals, some of which are sourced internationally, and tariffs imposed on these imported inputs can increase manufacturing costs for companies producing IUDs for distribution in the US.

US import data from the USITC DataWeb shows that total US imports for consumption of medical devices under various Harmonized Tariff Schedule (HTS) chapters amounted to billions of US dollars in 2023, and tariffs applied within these broader categories can influence overall costs for medical device manufacturers. These increased input costs present a financial challenge for manufacturers and could potentially influence the pricing of these devices, impacting affordability for healthcare providers and patients.

However, the high demand for effective contraception and the long-term cost-effectiveness of IUDs compared to alternative methods mean that manufacturers will likely endeavor to mitigate cost increases, and the public health imperative to improve access to IUDs encourages efforts to maintain their availability.

Latest Trends

Development of smaller, lower-dose, and more comfortable IUDs is a recent trend

Development of smaller, lower-dose, and more comfortable IUDs is a recent trend in the intrauterine contraceptive devices (IUD) market. Manufacturers are focusing on innovating IUD designs to enhance user experience and minimize potential side effects, thereby increasing their appeal. This includes creating smaller-sized IUDs that may be better tolerated by nulliparous individuals or those with smaller uterine cavities, as well as developing hormonal IUDs that release lower levels of progestin to potentially reduce systemic hormonal effects.

The aim of these developments is to improve comfort during insertion and throughout the period of use, decrease rates of premature expulsion, and expand the suitability of IUDs for a broader range of potential users. Companies within the women’s healthcare sector are actively pursuing research and development in this area to introduce next-generation devices to the market.

Regional Analysis

North America is leading the Intrauterine Contraceptive Devices (IUD) Market

North America dominated the market with the highest revenue share of 39.6% owing to increasing awareness of their effectiveness and long-term convenience. The Centers for Disease Control and Prevention (CDC) provides data on contraceptive use in the US. Their National Center for Health Statistics (NCHS) data indicates a trend towards increased utilization of long-acting reversible contraceptive (LARC) methods, including IUDs. This trend is supported by initiatives from organizations like the American College of Obstetricians and Gynecologists (ACOG), which recommend IUDs as safe and effective options for a wide range of women, including adolescents.

ACOG emphasizes the safety and efficacy of IUDs, which contributes to their growing acceptance among healthcare providers and patients. The availability of various IUD types, including hormonal IUDs with varying durations of use and non-hormonal copper IUDs, offers women a range of choices to suit their individual needs, further contributing to their increased adoption.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia Pacific is expected to grow with the fastest CAGR owing to increasing population and family planning initiatives. Many countries in the region are implementing programs to improve access to contraception, and IUDs are often included as a key component of these programs. For instance, public health programs in countries like India and China promote IUDs due to their high effectiveness and cost-effectiveness.

The World Health Organization (WHO) plays a role in supporting the use of IUDs as a safe and effective contraceptive method in the Asia Pacific region. WHO guidelines emphasize the importance of providing women with a range of contraceptive options, including IUDs, to enable informed choices about family planning. The increasing focus on women’s health and reproductive rights across the Asia Pacific region is also anticipated to contribute to the greater utilization of IUDs.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

Key players in the IUD market focus on expanding their product portfolios, improving patient access, and increasing awareness about the benefits of long-acting reversible contraceptives (LARCs). They invest heavily in research and development to introduce advanced IUD technologies, such as hormone-releasing devices, that enhance effectiveness and minimize side effects.

Strategic partnerships with healthcare providers and governments help these companies strengthen distribution channels and promote family planning initiatives. Additionally, they focus on increasing market penetration in emerging economies by improving access to reproductive health services. Companies also emphasize regulatory compliance and education to overcome cultural barriers and increase adoption rates.

Medtronic is a leading player in the global IUD market, known for offering a variety of healthcare solutions, including contraceptive devices. The company’s NuvaRing, a hormonal IUD, has gained significant market traction due to its effectiveness and ease of use. Medtronic’s growth strategy includes expanding its product line, collaborating with public health organizations, and increasing awareness about contraceptive options through educational campaigns. The company’s focus on innovation and expanding its global footprint helps it maintain a leading position in the market.

Top Key Players

• SMB Corporation of India
• Prosan International BV
• Pregna International Limited
• OCON Therapeutics
• DKT International
• CooperSurgical Inc
• Bayer AG
• AbbVie Inc

Recent Developments

• In July 2024, OCON Therapeutics, an Israeli women’s health company, secured US$10 million in funding to expand its offerings, including painless and highly effective IUDs and treatments for endometriosis. With a total of US$40 million raised, OCON is poised to enhance the IUD market by introducing user-friendly and accessible solutions, further driving demand in the growing women’s health segment.
• In November 2023, Bayer entered a development and licensing agreement with CrossBay Medical to create a single-handed inserter for intrauterine devices. This collaboration aims to integrate CrossBay’s CrossGlide technology with Bayer’s hormonal IUD products, enhancing ease of use and potentially expanding market penetration as the development of more practical, user-friendly IUD insertion methods becomes a key factor in driving the market.

Report Scope